The present invention relates to an ophthalmic formulation comprising citicoline and liposomes to be used in treating glaucoma. The inventors have found that the liposomes result to be particularly effective in carrying citicoline in the posterior segment of the eye (vitreous chamber) and in reaching the retina and the optic nerve head.